ZENTALIS PHARMACEUTICALS INC (ZNTL) Stock Price, Quote, News and Overview
NASDAQ:ZNTL - Nasdaq - US98943L1070 - Common Stock - Currency: USD
ZNTL Quote, Performance and Key Statistics
ZENTALIS PHARMACEUTICALS INC
NASDAQ:ZNTL (1/30/2025, 6:47:50 PM)
After market: 1.68 +0.02 (+1.2%)1.66
-0.23 (-12.17%)
The current stock price of ZNTL is 1.66 USD. In the past month the price decreased by -43.15%. In the past year, price decreased by -85.68%.
ZNTL Latest News, Press Releases and Analysis
These stocks that are showing activity before the opening bell on Wednesday.
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+...
Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development
Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2
Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies
Azenosertib Fast Track Designation granted for Cyclin E1 positive patients by U.S. Food and Drug Administration (FDA) Manuscript focused on role of Cyclin...
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and...
ZNTL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.34 | 310.40B | ||
| AMGN | AMGEN INC | 14.78 | 152.67B | ||
| GILD | GILEAD SCIENCES INC | 21.88 | 120.83B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 859.61 | 112.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.04 | 75.06B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.81B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.75B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.13B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.16B | ||
| NTRA | NATERA INC | N/A | 23.27B | ||
| BIIB | BIOGEN INC | 8.95 | 21.31B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.49B |
Related stock screener links
About ZNTL
Company Profile
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. The company is headquartered in San Diego, California and currently employs 168 full-time employees. The company went IPO on 2020-04-03. The firm is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The firm is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The firm is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Company Info
ZENTALIS PHARMACEUTICALS INC
10275 Science Center Drive, Suite 200
San Diego CALIFORNIA 10018 US
CEO: Anthony Y. Sun
Employees: 124
Company Website: https://www.zentalis.com/
Investor Relations: https://ir.zentalis.com/
Phone: 18582634333
ZNTL FAQ
What is the stock price of ZNTL?
The current stock price of ZNTL is 1.66 USD.
What is the symbol for ZENTALIS PHARMACEUTICALS INC stock?
The exchange symbol of ZENTALIS PHARMACEUTICALS INC is ZNTL and it is listed on the Nasdaq exchange.
On which exchange is ZNTL stock listed?
ZNTL stock is listed on the Nasdaq exchange.
Is ZNTL a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ZNTL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ZNTL.
Does ZNTL stock pay dividends?
ZNTL does not pay a dividend.
What is the Price/Earnings (PE) ratio of ZNTL?
ZNTL does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.59).
What is the Short Interest ratio of ZNTL stock?
The outstanding short interest for ZNTL is 7.04% of its float.
ZNTL Technical Analysis
ZNTL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ZNTL. No worries on liquidiy or solvency for ZNTL as it has an excellent financial health rating, but there are worries on the profitability.
ZNTL Financial Highlights
Over the last trailing twelve months ZNTL reported a non-GAAP Earnings per Share(EPS) of -2.59. The EPS decreased by 44.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -39.78% | ||
| ROE | -50.6% | ||
| Debt/Equity | 0 |
ZNTL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to ZNTL. The Buy consensus is the average rating of analysts ratings from 17 analysts.